Saptalis Pharmaceuticals LLC was founded in 2015 with a goal to build a successful pharmaceutical company focused on the development, manufacturing and commercialization of specialty generic prescription (Rx) and Over-The- Counter (OTC) products.
Saptalis operates at a 10,000 sq. ft. R&D facility with highly qualified and experienced team of pharmaceutical formulation scientists, analytical chemists and compliance specialists in regulatory affairs and pharmaceutical product manufacturing.
The facility is fully equipped with state of the art equipment used in pharmaceutical product development and analytical method development and validation process. The facility and its operations are set up to meet cGMP requirements.
Core competency of the group includes formulation development, process optimization, analytical method development and validation of dosage forms in non-sterile/sterile liquid and semi-solid product category.
We focus on products in niche areas, difficult to develop and with high barriers for FDA market approval and lower competition.